{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:07:16Z","timestamp":1749269236728,"version":"3.41.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,6]]},"DOI":"10.7759\/cureus.85478","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T18:14:56Z","timestamp":1749233696000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Post-transplant Lymphoproliferative Disorder After Successful Treatment of Islet Transplantation Without Graft Rejection"],"prefix":"10.7759","author":[{"given":"Koki","family":"Kurahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Anazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Fujikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuro","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/db25-0037","article-title":"Advances in cell replacement therapies for diabetes","author":"Hering BJ","year":"2025","unstructured":"Hering BJ, Rickels MR, Bellin MD, et al.. Advances in cell replacement therapies for diabetes. Diabetes. 2025, 10.2337\/db25-0037","journal-title":"Diabetes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1702693","article-title":"Post-transplantation lymphoproliferative disorders in adults","volume":"378","author":"Dierickx D","year":"2018","unstructured":"Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018, 378:549-62. 10.1056\/NEJMra1702693","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation","volume":"355","author":"Shapiro AM","year":"2006","unstructured":"Shapiro AM, Ricordi C, Hering BJ, et al.. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006, 355:1318-30. 10.1056\/NEJMoa061267","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3727\/096368911X582732","article-title":"Evaluation of viable \u03b2-cell mass is useful for selecting collagenase for human islet isolation: comparison of collagenase NB1 and liberase HI","volume":"21","author":"Misawa R","year":"2012","unstructured":"Misawa R, Ricordi C, Miki A, et al.. Evaluation of viable \u03b2-cell mass is useful for selecting collagenase for human islet isolation: comparison of collagenase NB1 and liberase HI. Cell Transplant. 2012, 21:39-47. 10.3727\/096368911X582732","journal-title":"Cell Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1779","article-title":"Improved health-related quality of life in a Phase 3 Islet Transplantation Trial in type 1 diabetes complicated by severe hypoglycemia","volume":"41","author":"Foster ED","year":"2018","unstructured":"Foster ED, Bridges ND, Feurer ID, Eggerman TL, Hunsicker LG, Alejandro R. Improved health-related quality of life in a Phase 3 Islet Transplantation Trial in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care. 2018, 41:1001-8. 10.2337\/dc17-1779","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13458","article-title":"Long-term follow-up of the Edmonton protocol of islet transplantation in the United States","volume":"16","author":"Brennan DC","year":"2016","unstructured":"Brennan DC, Kopetskie HA, Sayre PH, et al.. Long-term follow-up of the Edmonton protocol of islet transplantation in the United States. Am J Transplant. 2016, 16:509-17. 10.1111\/ajt.13458","journal-title":"Am J Transplant"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ags3.12214","article-title":"Current state and future evolution of pancreatic islet transplantation","volume":"3","author":"Anazawa T","year":"2019","unstructured":"Anazawa T, Okajima H, Masui T, Uemoto S. Current state and future evolution of pancreatic islet transplantation. Ann Gastroenterol Surg. 2019, 3:34-42. 10.1002\/ags3.12214","journal-title":"Ann Gastroenterol Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001765","article-title":"Efficacy and safety of allogeneic islet transplantation demonstrated by a multicenter clinical trial in Japan","volume":"11","author":"Anazawa T","year":"2025","unstructured":"Anazawa T, Marubashi S, Kodama S, et al.. Efficacy and safety of allogeneic islet transplantation demonstrated by a multicenter clinical trial in Japan. Transplant Direct. 2025, 11:e1765. 10.1097\/TXD.0000000000001765","journal-title":"Transplant Direct"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2019.101229","article-title":"Immunoglobulin abnormalities in 1677 solid organ transplant recipients. Implications for posttransplantation follow-up","volume":"57","author":"Se\u010dn\u00edk P Jr","year":"2019","unstructured":"Se\u010dn\u00edk P Jr, Jabor A, Lavr\u00edkov\u00e1 P, Se\u010dn\u00edk J, Mal\u00edkov\u00e1 P, Pokorn\u00e1 E, Franekov\u00e1 J. Immunoglobulin abnormalities in 1677 solid organ transplant recipients. Implications for posttransplantation follow-up. Transpl Immunol. 2019, 57:101229. 10.1016\/j.trim.2019.101229","journal-title":"Transpl Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-13150-4_13","article-title":"Post-transplant lymphoproliferative disorders","volume":"165","author":"Singavi AK","year":"2015","unstructured":"Singavi AK, Harrington AM, Fenske TS. Post-transplant lymphoproliferative disorders. Cancer Treat Res. 2015, 165:305-27. 10.1007\/978-3-319-13150-4_13","journal-title":"Cancer Treat Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(11)70300-x","article-title":"Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial","volume":"13","author":"Trappe R","year":"2012","unstructured":"Trappe R, Oertel S, Leblond V, et al.. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol. 2012, 13:196-206. 10.1016\/s1470-2045(11)70300-x","journal-title":"Lancet Oncol"},{"key":"ref12","unstructured":"NCCN Clinical Practice Guidelines in Oncology. B-Cell Lymphomas, Version 2. (2025). Accessed: April 20, 2025: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14303","article-title":"Posttransplant lymphoproliferative disorder after clinical islet transplantation: report of the first two cases","volume":"17","author":"Peters A","year":"2017","unstructured":"Peters A, Olateju T, Deschenes J, Shankarnarayan SH, Chua N, Shapiro AM, Senior P. Posttransplant lymphoproliferative disorder after clinical islet transplantation: report of the first two cases. Am J Transplant. 2017, 17:2474-80. 10.1111\/ajt.14303","journal-title":"Am J Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02691.x","article-title":"Posttransplant lymphoproliferative disorder following pancreas transplantation","volume":"9","author":"Issa N","year":"2009","unstructured":"Issa N, Amer H, Dean PG, et al.. Posttransplant lymphoproliferative disorder following pancreas transplantation. Am J Transplant. 2009, 9:1894-902. 10.1111\/j.1600-6143.2009.02691.x","journal-title":"Am J Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02772.x","article-title":"Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression","volume":"9","author":"Trappe R","year":"2009","unstructured":"Trappe R, Hinrichs C, Appel U, et al.. Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression. Am J Transplant. 2009, 9:2331-7. 10.1111\/j.1600-6143.2009.02772.x","journal-title":"Am J Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/375206-a-case-of-post-transplant-lymphoproliferative-disorder-after-successful-treatment-of-islet-transplantation-without-graft-rejection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T18:14:57Z","timestamp":1749233697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/375206-a-case-of-post-transplant-lymphoproliferative-disorder-after-successful-treatment-of-islet-transplantation-without-graft-rejection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.85478","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}